GlassScriptPhysician profile
Marcia Halpern
NPI 1275556789
$1,765.11
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $276 · 2021: $1,189 · 2022: $46.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $891.16 | 2021 | |
| Supernus Pharmaceuticals, INC. | $198.16 | 2019 | |
| Ucb, INC. | $86.04 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $73.75 | 2020-2021 | |
| Neurelis, INC. | $67.86 | 2020-2021 | |
| Amgen INC. | $65.86 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $65.39 | 2021 | |
| Alexion Pharmaceuticals, INC. | $63.79 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $40.21 | 2020 | |
| Biogen, INC. | $35.84 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.47 | 2022 | |
| Boston Scientific Corporation | $29.11 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $23.30 | 2020 | |
| Mdd US Operations, LLC | $22.35 | 2020 | |
| Lilly USA, LLC | $16.73 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $15.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.71 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $13.56 | 2021 | |
| Celgene Corporation | $11.87 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Halpern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.